annual cash & cash equivalents:
$484.60M-$369.30M(-43.25%)Summary
- As of today (August 19, 2025), WST annual cash & cash equivalents is $484.60 million, with the most recent change of -$369.30 million (-43.25%) on December 31, 2024.
- During the last 3 years, WST annual cash & cash equivalents has fallen by -$278.00 million (-36.45%).
- WST annual cash & cash equivalents is now -45.81% below its all-time high of $894.30 million, reached on December 31, 2022.
Performance
WST Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$509.70M+$105.50M(+26.10%)Summary
- As of today (August 19, 2025), WST quarterly cash & cash equivalents is $509.70 million, with the most recent change of +$105.50 million (+26.10%) on June 30, 2025.
- Over the past year, WST quarterly cash & cash equivalents has increased by +$63.50 million (+14.23%).
- WST quarterly cash & cash equivalents is now -43.28% below its all-time high of $898.60 million, reached on September 30, 2023.
Performance
WST quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
WST Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -43.3% | +14.2% |
| 3 y3 years | -36.5% | -29.1% |
| 5 y5 years | - | +14.3% |
WST Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -45.8% | at low | -43.3% | +26.1% |
| 5 y | 5-year | -45.8% | at low | -43.3% | +26.1% |
| alltime | all time | -45.8% | >+9999.0% | -43.3% | >+9999.0% |
WST Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $509.70M(+26.1%) |
| Mar 2025 | - | $404.20M(-16.6%) |
| Dec 2024 | $484.60M(-43.2%) | $484.60M(-1.3%) |
| Sep 2024 | - | $490.90M(+10.0%) |
| Jun 2024 | - | $446.20M(-25.9%) |
| Mar 2024 | - | $601.80M(-29.5%) |
| Dec 2023 | $853.90M(-4.5%) | $853.90M(-5.0%) |
| Sep 2023 | - | $898.60M(+12.8%) |
| Jun 2023 | - | $796.30M(-10.2%) |
| Mar 2023 | - | $886.30M(-0.9%) |
| Dec 2022 | $894.30M(+17.3%) | $894.30M(+22.7%) |
| Sep 2022 | - | $729.00M(+1.5%) |
| Jun 2022 | - | $718.50M(+7.6%) |
| Mar 2022 | - | $667.70M(-12.4%) |
| Dec 2021 | $762.60M(+23.9%) | $762.60M(+10.8%) |
| Sep 2021 | - | $688.00M(+19.4%) |
| Jun 2021 | - | $576.20M(+19.1%) |
| Mar 2021 | - | $483.70M(-21.4%) |
| Dec 2020 | $615.50M(+1161.3%) | $615.50M(+18.5%) |
| Sep 2020 | - | $519.40M(+16.5%) |
| Jun 2020 | - | $445.90M(+33.0%) |
| Mar 2020 | - | $335.30M(+88.3%) |
| Mar 2016 | - | $178.10M(-29.3%) |
| Jun 2015 | - | $252.00M(+174.5%) |
| Dec 2011 | - | $91.80M(+36.0%) |
| Jun 2010 | - | $67.50M(-61.9%) |
| Jun 2007 | - | $177.30M(+748.3%) |
| Dec 2005 | $48.80M(-29.1%) | - |
| Sep 2005 | - | $20.90M(-66.0%) |
| Jun 2005 | - | $61.50M(+13.9%) |
| Mar 2005 | - | $54.00M(-21.5%) |
| Dec 2004 | $68.80M(+82.0%) | $68.80M(+8.7%) |
| Sep 2004 | - | $63.30M(+19.7%) |
| Jun 2004 | - | $52.90M(+30.3%) |
| Mar 2004 | - | $40.60M(+7.4%) |
| Dec 2003 | $37.80M(+13.9%) | $37.80M(-30.6%) |
| Sep 2003 | - | $54.50M(+23.0%) |
| Jun 2003 | - | $44.30M(+19.4%) |
| Mar 2003 | - | $37.10M(+11.7%) |
| Dec 2002 | $33.20M(-21.1%) | $33.20M(-7.0%) |
| Sep 2002 | - | $35.70M(+27.5%) |
| Jun 2002 | - | $28.00M(-3.1%) |
| Mar 2002 | - | $28.90M(-31.4%) |
| Dec 2001 | $42.10M(-1.4%) | $42.10M(+1.2%) |
| Sep 2001 | - | $41.60M(+5.9%) |
| Jun 2001 | - | $39.30M(+4.0%) |
| Mar 2001 | - | $37.80M(-11.5%) |
| Dec 2000 | $42.70M | $42.70M(+2.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2000 | - | $41.60M(+11.5%) |
| Jun 2000 | - | $37.30M(-32.2%) |
| Mar 2000 | - | $55.00M(+21.4%) |
| Dec 1999 | $45.30M(+44.7%) | $45.30M(+20.8%) |
| Sep 1999 | - | $37.50M(-5.3%) |
| Jun 1999 | - | $39.60M(+20.0%) |
| Mar 1999 | - | $33.00M(+5.4%) |
| Dec 1998 | $31.30M(-40.2%) | $31.30M(-37.4%) |
| Sep 1998 | - | $50.00M(+2.9%) |
| Jun 1998 | - | $48.60M(-26.8%) |
| Mar 1998 | - | $66.40M(+27.0%) |
| Dec 1997 | $52.30M(+90.9%) | $52.30M(-1.5%) |
| Sep 1997 | - | $53.10M(+28.3%) |
| Jun 1997 | - | $41.40M(+43.3%) |
| Mar 1997 | - | $28.90M(+5.5%) |
| Dec 1996 | $27.40M(+57.5%) | $27.40M(+24.0%) |
| Sep 1996 | - | $22.10M(+47.3%) |
| Jun 1996 | - | $15.00M(+5.6%) |
| Mar 1996 | - | $14.20M(-18.4%) |
| Dec 1995 | $17.40M(-36.0%) | $17.40M(+0.6%) |
| Sep 1995 | - | $17.30M(+13.1%) |
| Jun 1995 | - | $15.30M(-47.1%) |
| Mar 1995 | - | $28.90M(+6.3%) |
| Dec 1994 | $27.20M(+423.1%) | $27.20M(+76.6%) |
| Sep 1994 | - | $15.40M(+75.0%) |
| Jun 1994 | - | $8.80M(+27.5%) |
| Mar 1994 | - | $6.90M(+32.7%) |
| Dec 1993 | $5.20M(+73.3%) | $5.20M(+116.7%) |
| Sep 1993 | - | $2.40M(-4.0%) |
| Jun 1993 | - | $2.50M(-51.9%) |
| Mar 1993 | - | $5.20M(+73.3%) |
| Dec 1992 | $3.00M(+11.1%) | $3.00M(+100.0%) |
| Sep 1992 | - | $1.50M(-21.1%) |
| Jun 1992 | - | $1.90M(+72.7%) |
| Mar 1992 | - | $1.10M(-59.3%) |
| Dec 1991 | $2.70M(+22.7%) | $2.70M(+107.7%) |
| Sep 1991 | - | $1.30M(+160.0%) |
| Jun 1991 | - | $500.00K(+66.7%) |
| Mar 1991 | - | $300.00K(-86.4%) |
| Dec 1990 | $2.20M(+37.5%) | $2.20M(-15.4%) |
| Sep 1990 | - | $2.60M(-3.7%) |
| Jun 1990 | - | $2.70M(+145.5%) |
| Mar 1990 | - | $1.10M(-31.3%) |
| Dec 1989 | $1.60M(-68.6%) | $1.60M(-68.6%) |
| Dec 1988 | $5.10M(-59.8%) | $5.10M(-59.8%) |
| Dec 1987 | $12.70M(+71.6%) | $12.70M(+71.6%) |
| Dec 1986 | $7.40M(-12.9%) | $7.40M(-12.9%) |
| Dec 1985 | $8.50M(+102.4%) | $8.50M(+102.4%) |
| Dec 1984 | $4.20M | $4.20M |
FAQ
- What is West Pharmaceutical Services, Inc. annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for West Pharmaceutical Services, Inc.?
- What is West Pharmaceutical Services, Inc. annual cash & cash equivalents year-on-year change?
- What is West Pharmaceutical Services, Inc. quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for West Pharmaceutical Services, Inc.?
- What is West Pharmaceutical Services, Inc. quarterly cash & cash equivalents year-on-year change?
What is West Pharmaceutical Services, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of WST is $484.60M
What is the all time high annual cash & cash equivalents for West Pharmaceutical Services, Inc.?
West Pharmaceutical Services, Inc. all-time high annual cash & cash equivalents is $894.30M
What is West Pharmaceutical Services, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, WST annual cash & cash equivalents has changed by -$369.30M (-43.25%)
What is West Pharmaceutical Services, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of WST is $509.70M
What is the all time high quarterly cash & cash equivalents for West Pharmaceutical Services, Inc.?
West Pharmaceutical Services, Inc. all-time high quarterly cash & cash equivalents is $898.60M
What is West Pharmaceutical Services, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, WST quarterly cash & cash equivalents has changed by +$63.50M (+14.23%)